Tokyo rebounded in the week ended November 3 (four trading days because November 3 was a national holiday in Japan). The Nikkei 225 leapt 19.7%, regaining the 8,500 level at the close, while the Topix index advanced 16.2%. To some extent, the market's recovery appeared to be a technical bounceback. However, investor sentiment was brightened by certain measures taken by the Japanese government to cope with the financial crisis and economic downturn. It announced an economic stimulus package worth 26,900.0 billion yen ($271.9 billion) and the Bank of Japan decided to trim the interest rate by 0.2 percentage points. Meanwhile, many players remained cautious about Japanese first-half earnings reports which are due in the next few weeks, anticipating that export-oriented companies may revise down their full-year projections due to the recently-strong yen and weaker demand overseas. The pharmaceutical index was up 11.0%, underperforming the market.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze